Purchases and Sales Made in Q2 2024 in Nautilus Biotechnology, Inc. (NAUT)
This table provides information about the institutional ownership of Nautilus Biotechnology, Inc. (NAUT) during Q2 2024. The information is specifically focused on institutions that hold shares of Nautilus Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85K- 20.91% |
$189K - $255K
|
322K
$286K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85K- 20.91% |
$189K - $255K
|
322K
$286K
|
|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-136K- 4.75% |
$301K - $407K
|
2.72M
$2.42M
|